Insulet

Insulet is a prominent medical device manufacturer founded in 2000, specializing in innovative insulin delivery solutions. The company is best known for its Omnipod Insulin Management System, a wearable, disposable pod that provides up to three days of continuous insulin delivery without the need for needles. By simplifying the management of diabetes, Insulet has established a significant presence in the medical technology sector. The company is actively expanding its proprietary technology platform to facilitate the subcutaneous delivery of non-insulin drugs across various therapeutic areas, demonstrating a commitment to diversifying its clinical applications and improving patient outcomes through advanced engineering.

Operating with a workforce of 5,000-10,000 employees, Insulet maintains a robust operational footprint to support its global manufacturing and distribution requirements. The organization manages its strategic activities from its primary corporate base in Massachusetts. Learn about Insulet's global headquarters for detailed information regarding their geographic presence and operational infrastructure. The company’s focus on scalable manufacturing processes ensures that its medical devices meet rigorous safety and quality standards, supporting its position as a leader in the competitive medical device market.

Insulet reported annual revenue of $2.9B, reflecting its strong market position and the widespread adoption of its insulin management technology. Explore financial highlights to review detailed performance metrics and funding history. The company competes with major industry players such as Medtronic and Dexcom, continuously innovating to maintain its competitive edge. Meet Insulet's team to learn more about the leadership driving these advancements. With a focus on B2B and B2C channels, Insulet remains dedicated toView more...